Immunotherapie and Immunology news
Type 1 diabetes has long been considered a lifelong condition, requiring constant management and insulin therapy. However, recent developments in stem cell research are challenging this notion and offering hope for a potential cure. This article explores the groundbreaking study by Vertex Pharmaceuticals that’s making waves in the diabetes community and could revolutionize treatment for […]
Read More »In a landmark development for stem cell research and diabetes treatment, Vertex Pharmaceuticals has achieved remarkable success with their investigational therapy VX-880 for type 1 diabetes (T1D). This breakthrough, based on longstanding research from Harvard Stem Cell Institute’s Melton Lab, represents one of the first practical applications of embryonic stem cells in treating a major […]
Read More »Scientists are developing a promising approach for treating type 1 diabetes by using stem cells to create insulin-producing cells (called beta cells) that could replace nonfunctional pancreatic cells.
Read More »People with type 2 diabetes tend to have poorer muscle function than others. Now a research team has discovered that in type 2 diabetes, a specific gene is of great importance for the ability of muscle stem cells to create new mature muscle cells.
Read More »